High Cholesterol

Medication access remains a hurdle for many patients, especially those prescribed cholesterol-lowering PCSK9 inhibitors.

Social Media Graphic

Social Media Graphic

Social Media Graphic

Infographic

Social media graphic

Social media graphic

Social media graphic

Infographic

Social media graphic

Social media graphic

Social media graphic

Social media graphic

Social media graphic

Social media graphic

Cardiovascular disease has long been the number one overall cause of death in the United States. Forecasts indicate the situation will worsen.

Arizona’s rate of heart disease is higher than the national average. Yet insurers are more likely to reject Arizonans’ prescriptions for cholesterol-lowering medication.

Oklahoma’s rate of heart disease is higher than the national average. Yet insurers are more likely to reject Oklahomans’ prescriptions for cholesterol-lowering medication.

Texas’ rate of heart disease is higher than the national average. Yet insurers are more likely to reject Texans’ prescriptions for cholesterol-lowering medication.

Arkansas’ rate of heart disease is higher than the national average. Yet insurers are more likely to reject Arkansans’ prescriptions for cholesterol-lowering medication.

Every 36 seconds, someone in the United States dies from cardiovascular disease. In fact, heart disease is the leading cause of death in America, responsible for one in every four adult fatalities. Making sure patients can access medication that protects their hearts should be a top national health care priority. But recent insurance claims data […]

Angie Peterson was diagnosed with FH. Her doctor recommended one treatment - but her insurance forced her on another.

Darin Burnham had a heart attack and was denied his doctor-prescribed medication to manage his condition. Hear his story.

Latrice Baxter went in for routine heart screens and several hours later found herself on the operating table. Hear her story.

When it comes to high cholesterol, access to the right medication could be a matter of life or death.

One-fourth of the world’s population faces a cardiovascular risk that they’ve probably never heard of: Lp(a).

Pat and her doctor worked together to find the best treatment option to help lower her cholesterol.

Lea has struggled with statins in the past. But she’s not giving up the fight to lower her cholesterol.

For generations, Sissy’s family has dealt with high cholesterol. In this video, she shares her struggles with statins and explains why a patient-centered approach to high cholesterol treatment is necessary.

Managing high cholesterol isn’t one-size-fits-all. If the first statin isn’t right, patients and health care providers can work together to find the best treatment path.

Jeff’s story explains why it’s so important to support medical innovation – and access to new medicines that result from that innovation.